PMC:7073332 / 7170-8507
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
173 | 215-220 | Species | denotes | human | Tax:9606 |
174 | 236-253 | Species | denotes | Human coronavirus | Tax:694448 |
175 | 520-525 | Species | denotes | human | Tax:9606 |
176 | 884-889 | Species | denotes | human | Tax:9606 |
177 | 1093-1098 | Species | denotes | human | Tax:9606 |
178 | 1319-1324 | Species | denotes | human | Tax:9606 |
179 | 255-259 | Species | denotes | HCoV | Tax:694448 |
180 | 347-351 | Species | denotes | HCoV | Tax:694448 |
181 | 417-421 | Species | denotes | HCoV | Tax:694448 |
182 | 821-825 | Species | denotes | HCoV | Tax:694448 |
183 | 1246-1255 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T22 | 277-285 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T23 | 352-359 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T24 | 433-441 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T25 | 526-533 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T26 | 558-562 | Body_part | denotes | Gene | http://purl.org/sig/ont/fma/fma74402 |
T27 | 974-982 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T28 | 1129-1137 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T29 | 1272-1279 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T30 | 1280-1287 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T28 | 1246-1255 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T45 | 71-72 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T46 | 168-173 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T47 | 215-220 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T48 | 234-235 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T49 | 236-241 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T50 | 341-342 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T51 | 343-346 | http://purl.obolibrary.org/obo/NCBITaxon_9596 | denotes | pan |
T52 | 372-373 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
T53 | 520-533 | http://purl.obolibrary.org/obo/PR_000029067 | denotes | human protein |
T54 | 558-562 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | Gene |
T55 | 884-889 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T56 | 1093-1098 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T57 | 1169-1170 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T58 | 1319-1324 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T71 | 108-116 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T72 | 195-199 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T73 | 221-224 | Chemical | denotes | PPI | http://purl.obolibrary.org/obo/CHEBI_53266|http://purl.obolibrary.org/obo/CHEBI_60614 |
T75 | 277-285 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T76 | 352-359 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T77 | 400-404 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T78 | 433-441 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T79 | 494-499 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T80 | 526-533 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T81 | 688-692 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T82 | 802-807 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T83 | 974-982 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T84 | 1129-1137 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T85 | 1152-1156 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T86 | 1209-1213 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T87 | 1236-1245 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T88 | 1272-1279 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T89 | 1280-1287 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 32-1337 | Sentence | denotes | Our network-based methodology combines a systems pharmacology-based network medicine platform that quantifies the interplay between the virus–host interactome and drug targets in the human PPI network. a Human coronavirus (HCoV)-associated host proteins were collected from literatures and pooled to generate a pan-HCoV protein subnetwork. b Network proximity between drug targets and HCoV-associated proteins was calculated to screen for candidate repurposable drugs for HCoVs under the human protein interactome model. c, d Gene set enrichment analysis was utilized to validate the network-based prediction. e Top candidates were further prioritized for drug combinations using network-based method captured by the “Complementary Exposure” pattern: the targets of the drugs both hit the HCoV–host subnetwork, but target separate neighborhoods in the human interactome network. f Overall hypothesis of the network-based methodology: (i) the proteins that functionally associate with HCoVs are localized in the corresponding subnetwork within the comprehensive human interactome network; and (ii) proteins that serve as drug targets for a specific disease may also be suitable drug targets for potential antiviral infection owing to common protein–protein interactions elucidated by the human interactome. |